AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE, AND OXYBENZONE and RECALLED PRODUCT ADMINISTERED

Overview

RECALLED PRODUCT ADMINISTERED is the #7 most commonly reported adverse reaction for AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE, AND OXYBENZONE, manufactured by Kenvue Brands LLC. There are 7 FDA adverse event reports linking AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE, AND OXYBENZONE to RECALLED PRODUCT ADMINISTERED. This represents approximately 2.6% of all 273 adverse event reports for this drug.

Patients taking AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE, AND OXYBENZONE who experience recalled product administered should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.

Reporting Frequency

RECALLED PRODUCT ADMINISTERED is a less commonly reported adverse event for AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE, AND OXYBENZONE, but still significant enough to appear in the safety profile.

Other Side Effects of AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE, AND OXYBENZONE

In addition to recalled product administered, the following adverse reactions have been reported for AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE, AND OXYBENZONE:

• SKIN CANCER — 32 reports
• BASAL CELL CARCINOMA — 14 reports
• NEOPLASM MALIGNANT — 13 reports
• MALIGNANT MELANOMA — 12 reports
• RASH — 11 reports
• BURNS THIRD DEGREE — 9 reports
• SUNBURN — 7 reports
• DRUG INEFFECTIVE — 6 reports
• PRURITUS — 6 reports
• SQUAMOUS CELL CARCINOMA — 6 reports

Other Drugs Associated with RECALLED PRODUCT ADMINISTERED

The following drugs have also been linked to recalled product administered in FDA adverse event reports:

Does AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE, AND OXYBENZONE cause RECALLED PRODUCT ADMINISTERED?

RECALLED PRODUCT ADMINISTERED has been reported as an adverse event in 7 FDA reports for AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE, AND OXYBENZONE. This does not prove causation, but indicates an association observed in post-market surveillance data.

How common is RECALLED PRODUCT ADMINISTERED with AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE, AND OXYBENZONE?

RECALLED PRODUCT ADMINISTERED accounts for approximately 2.6% of all adverse event reports for AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE, AND OXYBENZONE, making it a notable side effect.

What should I do if I experience RECALLED PRODUCT ADMINISTERED while taking AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE, AND OXYBENZONE?

If you experience recalled product administered while taking AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE, AND OXYBENZONE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.

Related Pages